A Complete Walkthrough of the Dermal Fillers OEM Process: Build Your Custom Aesthetic Brand the Right Way

If you’ve spent any time in the medical aesthetics space over the past 5 years, you’ve watched the dermal filler market explode. Clinics, medspa chains, and independent beauty brands are no longer satisfied reselling big-name, marked-up filler lines. They want to build their own product portfolios that match their client base’s exact needs, from soft lip plumping for first-time patients to structured mid-face volume restoration for mature skin. But most brand owners hit a wall the second they start looking into manufacturing: How does the dermal filler OEM process actually work? How do you avoid cut-rate facilities that cut corners on raw materials? How do you launch a line without tying up all your capital in sky-high minimum order quantities?

AIMA International Group Co., Ltd., founded in 2003, has spent two decades refining dermal filler manufacturing and OEM/ODM services for clients across 60+ countries, with full product portfolios available to browse at https://supplierfiller.com/. We’ve seen every possible misstep in the custom filler space, from botched formula batches to regulatory seizures of non-compliant products. We’ve also helped hundreds of brands launch lines that outperform global household names in their local markets, thanks to a transparent, client-centered production flow.

Why More Aesthetic Brands Are Opting for Dermal Filler OEM Instead of White-Label Resale

Generic white-label fillers come with fixed formulas, generic packaging, and zero room for adjustment. You take what the supplier gives you, pay their marked-up price, and compete with dozens of other brands selling the exact same product under different logos. OEM (original equipment manufacturing) for dermal fillers flips that model. You control every part of the product, from crosslinking density to lidocaine content to packaging design, so you can build a unique offering that stands out from crowded retail and clinic shelves.

Take Marta, a Barcelona-based clinic owner who reached out to our team in 2023. She’d spent 3 years building a loyal client base of 2,000+ patients, all asking for a softer, less swelling-prone filler tailored to mature skin. She initially tried reselling a popular global filler brand, but the 60% markup from the distributor ate into her margins, and she couldn’t adjust the product’s HA concentration to match what her clients wanted. She briefly worked with a small local OEM shop that offered rock-bottom prices, only to discover the facility used non-medical grade HA sourced from unvetted suppliers. Three patients developed prolonged granulomas after treatment, costing her €120,000 in settlement fees and nearly forcing her to close her clinic.

Stories like Marta’s are far too common. Brands jump into filler manufacturing without understanding the process, partner with the cheapest supplier they can find, and end up paying far more in refunds, legal fees, and reputational damage than they ever saved on production costs.

The Step-by-Step Dermal Filler OEM Process, From Initial Consult to Market Launch

Our OEM process is built to eliminate surprises for brand owners, with clear milestones and transparent communication at every stage. We don’t lock clients into rigid packages; every step is adjusted to match your brand size, target market, and launch timeline.

1. Initial Consultation & Goal Alignment

Every partnership starts with a 30-minute call with your dedicated project manager. We’ll walk through your core goals: Are you building a premium clinic-only line for high-net-worth patients? An accessible entry-level filler for medspas targeting 18-30 year old clients? Do you need products certified for the EU market, or registered for sale in North America, the Middle East, or Southeast Asia? We’ll also talk through your budget, launch timeline, and ideal price point for end customers, so we can build a production plan that fits your numbers.

2. Formula Selection & Customization

We hold a library of more than 1,000 proven dermal filler formulas, built on two core proprietary technologies that set our products apart from generic market offerings:

• NASHA (Non-Animal Stabilized Hyaluronic Acid) technology: This process creates highly biocompatible HA particles that integrate smoothly with native facial tissue, cutting post-treatment swelling by 30% compared to non-stabilized formulas, per internal testing across 120,000 administered doses. The non-animal origin eliminates risk of animal-related allergic reactions, a top concern for patients with sensitive skin.
• HICE (High Concentration Crosslinking Enhancement) technology: This crosslinking method creates durable, flexible HA bonds that hold volume for 12-18 months without migrating, a common pain point for patients who’ve had fillers shift to unintended facial areas like the under-eye or jowl region.

All our formulas use medical-grade, non-animal derived HA with a 99%+ purity level, sourced at a cost of $45,000 per kilogram. Every raw material batch comes from CE GMP-certified suppliers, and undergoes independent third-party testing via SGS to confirm no endotoxins, impurities, or cross-contamination before entering production. Clients can adjust every element of the formula: HA concentration, crosslinking ratio, particle size for different injection depths, lidocaine content for pain reduction, and even added active ingredients for skin rejuvenation benefits.

3. Production Facility Validation

Dermal fillers are classified as Class III medical devices in most global markets, which requires strict production controls to avoid contamination. Our 4,800 square meter modern production base operates 3 dedicated production lines inside a Class 100 GMP clean room, built to meet ISO 13485 quality management system standards and Class III medical device manufacturing specifications.

Clients are welcome to tour the facility in person, or join a live virtual walkthrough to see production flows, quality control checkpoints, and clean room operations before signing a production contract. We don’t hide our operations behind glossy stock photos; you’ll see exactly where your products are made, who is making them, and what quality checks happen at every stage.

4. Sample Development & Iteration

Once we lock in your initial formula parameters, our R&D team produces custom samples within 3-5 working days, shipped directly to your team for testing. We encourage clients to run both lab testing for rheological properties and clinical trials with a small group of patients to assess feel, longevity, swelling response, and pain during injection. We’ll iterate on the formula as many times as needed until you are fully satisfied with the product performance—no extra fees for sample adjustments.

5. Branding, Packaging & Regulatory Prep

While you test samples, our in-house design and regulatory teams get to work on the rest of your brand assets. We offer end-to-end support for brand positioning, logo design, custom packaging (from sleek luxury magnetic boxes for high-end lines to cost-effective clinical blister packs for high-volume medspas), and label copy that meets local market advertising regulations for medical devices.

Our regulatory team compiles all required documentation for your market, including CE certification files, FDA VCRP registration materials, safety data sheets, batch test reports, and technical files required for local medical device registration. We’ve helped clients register custom filler lines in 42 countries, so we know exactly what paperwork local regulators require to get your products through customs and onto shelves without delays.

6. Production, Quality Check & Delivery

Once you sign off on samples and packaging, we move your order into production. Our facility holds an annual production capacity of 5 million units, with monthly output of up to 50,000 units, so we can scale with your brand as you grow. We operate with a No MOQ Pressure policy for emerging brands, so you can place small initial orders to test market response without tying up capital in excess inventory. For large enterprise clients, we offer tiered bulk discounts to lower per-unit costs as order volumes increase.

Standard production timelines run 15-20 days for bulk orders, with expedited production options available for brands with tight launch deadlines. Every single unit goes through 3 separate quality checks before leaving the facility: raw material purity testing, post-production sterility testing, and final packaging inspection. We track every batch with a unique serial number, so you can trace every unit back to its original production date, raw material batch, and quality control sign-off.

We worked with a large Dubai-based medical aesthetic chain last year that had previously locked into a 10,000-unit minimum order with a European manufacturer, tying up $420,000 in inventory that sat in their warehouse for 18 months because they couldn’t adjust the order to match shifting client demand for lidocaine-containing fillers. When they switched to our OEM program, they started with an initial order of just 500 units of custom-formulated filler to test with their client base, then scaled up as demand grew. We first connected with their team at the 2024 Dubai Beauty Exhibition, where they tested sample formulations on site and signed their initial contract 3 days after the show.

7. Post-Launch Support

Our support doesn’t end when your order ships. We provide ongoing clinical training resources for your injector teams, marketing materials to help you promote your new line to clients, and fast response times for any quality or regulatory questions that come up after launch. If you need to adjust your formula, update packaging, or scale up order volumes as your brand grows, your dedicated project manager is just a message away.

Our Most Requested OEM Dermal Filler Formulation

Across the 521+ brands we’ve supported with custom dermal filler solutions, one formulation stands out as the most popular starting point for new lines: Facefill Lidocaine.

Facefill Lidocaine is a balanced hyaluronic acid dermal filler formulated with 0.3% lidocaine to cut injection pain for patients, without impacting product longevity or spreadability. Built with our NASHA technology, the formula has a medium crosslinking density that works for 90% of common facial filler use cases: smoothing nasolabial folds, adding subtle mid-face volume, softening perioral lines, and defining soft jawline contours. Independent clinical testing shows the formula integrates fully with native tissue within 72 hours, with 92% of patients reporting minimal to no pain during injection, compared to 38% of patients receiving non-lidocaine filler alternatives. We’ve helped 187 brands launch their own custom versions of this formula, adjusting HA concentration, particle size, and packaging to match everything from luxury clinic lines to accessible medspa entry-level products.

Red Flags to Watch for When Vetting Dermal Filler OEM Partners

The dermal filler OEM space is full of suppliers making big promises for rock-bottom prices, but many cut corners that put your brand and your patients at risk. Keep an eye out for these warning signs when evaluating potential partners:

• No transparent raw material records: If a manufacturer can’t show you third-party SGS or equivalent test reports for their HA raw material, or quotes prices well below the market rate for medical-grade HA, walk away. Cut-rate HA is often sourced from untested animal-derived or industrial-grade stock that carries high risks of allergic reaction, granuloma formation, and long-term patient harm.
• Refusal to show production facilities: Any legitimate medical device manufacturer will offer in-person or virtual tours of their clean room production spaces. If a supplier only shares stock photos of facilities and refuses to connect you with past clients or show real production footage, they are likely operating out of an unregulated workshop with no proper contamination controls.
• Rigid, high minimum order requirements: Suppliers that demand 5,000+ unit minimums for first-time orders don’t have your brand’s best interest at heart. Launching a new filler line carries inherent market risk, and a good partner will let you test products with small runs before you commit to large inventory purchases.
• No regulatory support: Selling uncertified dermal fillers can lead to product seizures, heavy fines, or even criminal charges in most markets. If a supplier says “you handle registration on your own” with no supporting documentation, you will be left on the hook for all compliance risk.

As a recipient of the “Top 10 Dermal Filler Manufacturers” industry award, we hold our production processes to the highest global standards. All our products carry full EU CE certification and US FDA VCRP registration, with full traceability for every batch. We don’t cut corners on raw materials, we don’t hide our operations, and we don’t pressure clients into orders larger than they can handle.

We don’t promise overnight success. Building a trusted dermal filler brand takes 6-12 months of consistent work, from testing formulas to training clinical staff to building trust with patients. What we do offer is a transparent, straightforward OEM process that removes the manufacturing guesswork, so you can focus on what you do best: connecting with clients and building a brand that stands out in a crowded market. If you’re ready to explore a custom dermal filler line for your business, you can browse our full product portfolio and request free samples directly at https://supplierfiller.com/, or reach out to our team to get a custom quote tailored to your launch goals.